Publisher Correction: Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma - Summary - MDSpire

Publisher Correction: Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma

  • By

  • Jack Y. Ghannam

  • Julian Bryan

  • Jakob Weiss

  • Daniel Kovarsky

  • David Merrell

  • Conor Messer

  • Kristy Schlueter-Kuck

  • Geoffrey G. Fell

  • Mary Jane Lim-Fat

  • Gilbert Youssef

  • Rifaquat Rahman

  • Lei Qin

  • Geoffrey S. Young

  • J. Thomas Janes

  • McKayla Van Orden

  • Kathleen L. Pfaff

  • Andrew Gans

  • Emma S. Lin

  • Raymond Y. Huang

  • Brian P. Danysh

  • Laxmi Parida

  • Shuqiang Li

  • Patrick Y. Wen

  • E. Antonio Chiocca

  • Donna Neuberg

  • Keith L. Ligon

  • Itay Tirosh

  • David A. Reardon

  • Gad Getz

  • Catherine J. Wu

  • June 12, 2026

  • 0 min

Share

Objective:

To correct errors in the previously published article regarding the prognostic value of tumor transcriptional profiles in glioblastoma patients treated with immune checkpoint inhibition.

Approach:
    Key Findings:
    • Correction made to the description of the profiling method in the Abstract.
    • Correction made to the hazard ratio confidence interval in the cohort section.
    • Correction made to the title in Fig. 4e.
    Interpretation:

    Conclusion:

    The corrections have been implemented in the HTML and PDF versions of the article.

    Sources:

Original Source(s)

Related Content